AURISCO was founded in 1998
Operation Center in Shanghai was established
Set up Yang Zhou facility primarily for fermentation research and production
Tiantai Badu Industrial Park Zone Facility and Yangzhou facility was activated
FDA approval of Tiantai production plant
Started construction of new facility in Yangzhou
Established Aurisco Pharmaceutical (Joint Stock) Co., Ltd.
Acquired APTI from Apotex, established R&D Center in Tianjin
September 21, listed on the Shanghai Stock Exchange
On July 7, Shanghai Aurisco Biotechnology Co., Ltd. was established